2018 UK Drugs of Abuse Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

This new 260-page report provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.

During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.

Introduction
 Worldwide Market and Technology Overview
 A. Major Drugs of Abuse
 1. Overview
 2. Test Methodologies
 3. Amphetamines
 4. Barbiturates
 5. Benzodiazepines
 6. Cannabinoids/Marijuana
 7. Cocaine
 8. Lysergic Acid Diethylamide (LSD)
 9. Methadone
 10. Methaqualone
 11. Opiates
 12. Phencyclidine
 13. Tricyclic Antidepressants
 B. Instrumentation Review: Operating characteristics
 and features of high-, medium-, and low-volume/POC
 analyzers manufactured by Abaxis, Abbott, Alere/Inverness,
 Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
 Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
 Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
 Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
 C. Major In Vitro Diagnostic Technologies
 And Their Potential Applications
 1. Monoclonal and Polyclonal Antibodies
 2. Immunoassays
 a. Technological Principle
 d. Chemiluminescence
 c. Enzyme Immunoassays (EIA)
 ° Overview
 ° ELISA
 ° EMIT
 ° Electrochemical
 d. Radioimmunoassays (RIA)
 e. Immunoprecipitation
 f. Affinity Chromatography
 3. Tandem Mass Spec
 4. IT and Automation
 5. Dry Chemistry
 6. Biosensors
 D. Market Size, Growth and Major Supplier Shares
 Alternative Market Penetration Strategies
 A. Internal Development
 B. Collaborative Arrangements
 C. University Contracts
 D. Distribution Strategies for Decentralized
 Testing Markets
 1. Marketing Approaches
 2. Product Complexity
 3. Customer Preference
 4. Established Suppliers
 5. Emerging Suppliers
 6. Major Types of Distributors
 7. Market Segmentation
 Potential Market Entry Barriers and Risks
 A. Market Maturity
 B. Cost Containment
 C. Competition
 D. Technological Edge and Limitations
 E. Patent Protection
 F. Regulatory Constraints
 G. Decentralized Testing Market Challenges
 Competitive Assessments
 - Abbott Laboratories
 - AdnaGen/Alere
 - Agilent Technologies
 - Beckman Coulter/Danaher
 - Biomedical Diagnostics
 - BioMerieux
 - Bio-Rad
 - DiaSorin
 - Eiken
 - Fujirebio
 - Grifols
 - Instrumentation Laboratory
 - Kyowa Medex
 - Matritech/Alere
 - Ortho-Clinical Diagnostics
 - Quest Diagnostics
 - Roche
 - Siemens
 - Sysmex
 - Thermo Fisher
 - Tosoh
 - Wako
 - Wallac/PE


List Of Tables

Major Companies Developing or Marketing
Drugs of Abuse Tests
U.K., Drugs of Abuse Test Volume
Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse
Test Volume Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse
Test Volume Forecast by Assay
U.K., Drugs of Abuse Reagent Market
Forecast By Market Segment
U.K., All Market Segments, Drugs of Abuse
Reagent Market Forecast by Assay
U.K., Hospital Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
U.K., Commercial/Private Laboratories, Drugs of Abuse
Reagent Market Forecast by Assay
U.K., Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares


2018 Healthcare Research Review

Report Scope:The scope of this report is broad. It covers components, applications, end users and modes of deployment in 3D medical and surgical platforms. The market has been segmented by

USD 950 View Report

2019-2023 UK Drugs of Abuse Testing Market: Supplier Shares and Strategies, Country Test Volume and Sales Segment Forecasts

This new 260-page report from provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles

USD 2450 View Report

2018 UK Hepatitis Molecular and Immunodiagnostics Market: Supplier Shares and Strategies, Segmentation Forecasts--Blood Banks, Commercial Labs, Hospitals, Public Health Labs

Complete report $3,900.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available